Syndax Pharmaceuticals has announced (pdf) it has secured $80 million in series C financing.
Syndax, based in Waltham, Mass., is a clinical stage biopharmaceutical company. It is developing entinostat, an investigational, targeted, epigenetic immunomodulator, as a combination therapy in … Continue Reading
Incidences of skin cancer in the United States have increased over the past 30 years, especially among patients over the age of 60. As of 2014, 42 percent of dermatology patients were over the age of 60, and the U.S. … Continue Reading
WAVE Life Sciences has announced (pdf) it has secured $66 million in series B preferred stock financing.
WAVE Life Sciences, based in Boston, is a genetic medicine company focused on developing stereopure nucleic acid therapies for patients impacted by … Continue Reading
Metacrine has announced it has secured $36 million in funding.
Metacrine, based in San Diego, Calif., is a biotechnology company focused on advancing research in nuclear hormone receptors for treatment of metabolic diseases originated at the Salk Institute for … Continue Reading
In a report authored by CMS’s Office of the Actuary and published in Health Affairs, CMS projected that healthcare spending would grow by an average of 5.8% in the aggregate over 2014-2024. Such a rate is 1.1% higher than … Continue Reading
Deerfield Management Co. has announced the launch of a new $550 million healthcare venture-capital fund, Deerfield Healthcare Innovations Fund, L.P.
The firm indicated the new fund will invest in advancements in science that may lead to therapeutic interventions in genetic … Continue Reading
Medical Properties Trust (MPT) has announced it will acquire Capella Healthcare for $900 million in cash.
MPT is a Birmingham, Ala.-based self-advised real estate investment trust. Capella is one of the largest for-profit hospital companies in the U.S. Based in … Continue Reading
Oncobiologics has announced it has secured $31 million in funding.
Oncobiologics, based in Cranbury, N.J., is a biopharmaceutical company focused on developing and commercializing monoclonal antibody biosimilar therapeutics.
The investment round was led by new investor Perceptive Advisors. … Continue Reading
NaviMed Capital has announced (pdf) the closing of its inaugural healthcare private equity fund, NaviMed Partners, LP.
The fund has more than $110 million of total capital commitments.
NaviMed Capital, based in Washington, D.C., is focused exclusively on the … Continue Reading
Aetna will acquire Humana for a combination of cash and stock valued at $37 billion, according to a joint news release from the two insurers.
According to data supplied by the companies (pdf), Aetna is the larger of the companies, … Continue Reading
The U.S. Supreme Court has issued its King v. Burwell (pdf) decision regarding the validity of premium assistance issued by federally run insurance marketplaces.
In a 6-3 ruling, the Supreme Court upheld subsidies for the millions of people who have … Continue Reading
A recent flurry of activity in the health insurance industry would seem to indicate that investors can expect significant consolidation in the managed care sector.
As The Health Care M&A Information Source reports, it began in May, with Humana … Continue Reading
A new column from Becker’s Hospital Review identifies 50 things to know about healthcare costs.
Topics covered include the rise in spending; cost of hospital services; spending on drugs and services; and growing out-of-pocket costs.
These are interesting facts for … Continue Reading
The role of retail clinics in health care has been steadily and rapidly expanding in recent years, and private equity funds are taking note. The private equity community has actively invested in this arena with some regularity in the past … Continue Reading
Shockwave Medical has announced it has secured $40 million in funding.
Shockwave Medical, based in Fremont, Calif., develops technology for the treatment of peripheral and coronary vascular disease and aortic stenosis. It is the developer of Lithoplasty balloon catheters.… Continue Reading
Below is a link to view the latest entry from the monthly Law360 that we publish relating to healthcare private equity investments. This column was written by Geoff C. Cockrell and Amber McGraw Walsh, McGuireWoods LLP, together with Hunter Atkins … Continue Reading
Moximed has announced it has secured approximately $33 million in funding.
Moximed, based in Hayward, Calif., is focused on developing minimally invasive, joint preserving solutions for patients with knee osteoarthritis.
The funding round included new investor Vertex Venture Holdings… Continue Reading
Rapid Micro Biosystems has announced it has secured $25 million in series C funding.
Rapid Micro Biosystems, based in Lowell, Mass., develops imaging technology that detects microbial contamination in the manufacture of pharmaceutical, biotechnology and other products
The financing … Continue Reading
Spirox has announced it has secured $18.5 million in series B funding.
Spirox, based in Menlo Park, Calif., develops minimally invasive technologies to treat nasal obstruction.
The financing round was led by Venrock and Aisling Capital. Existing investors Aperture … Continue Reading
New Enterprise Associates (NEA) has announced it has closed its fifteenth fund — New Enterprise Associates 15 LP — with $2.8 billion in committed capital.
An additional $350 million is committed for NEA 15 Opportunity Fund, a co-investment fund.
NEA… Continue Reading
Health Diagnostics Laboratory (HDL) of Richmond, Va., has agreed to pay $47 million to resolve allegations it violated the False Claims Act by compensating physicians for ordering tests, according to a U.S. Department of Justice news release.
Laboratory Singulex … Continue Reading
Livongo Health has announced it has secured $20 million in series B funding.
Livongo, with offices in Chicago and Mountain View, Calif., is a developer of chronic disease management tools, including a cloud-enabled glucose meter.
Participating investors included Kleiner Perkins … Continue Reading
Lux Capital has announced it has closed a new $350 million fund that will invest in early-stage science and technology ventures.
Lux Capital, with offices in New York and Menlo Park, Calif., invests in counter-conventional, seed and early stage … Continue Reading
Tenet Healthcare Corp. has announced it has signed a definitive agreement with United Surgical Partners International (USPI) to combine their short-stay surgery and imaging center assets into a new joint venture.
Tenet will initially own 50.1% of the joint venture, … Continue Reading